Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.
about
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trialInsulin in central nervous system: more than just a peripheral hormoneMolecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisalDiverse molecular targets for therapeutic strategies in Alzheimer's diseaseIntranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the artRodent models of neuroinflammation for Alzheimer's diseaseAlcohol, insulin resistance and the liver-brain axisInsulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndromeFood for thought: the role of appetitive peptides in age-related cognitive declineTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseDiabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stressAberrant insulin signaling in Alzheimer's disease: current knowledgeBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseAlzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigeneticsBrain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicityStructure and dynamics of parallel beta-sheets, hydrophobic core, and loops in Alzheimer's A beta fibrilsIn vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocinEffects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal dietThe ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated miceExercise and cognitive function: a hypothesis for the association of type II diabetes mellitus and Alzheimer's disease from an evolutionary perspectiveEpidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis.Ceramide-mediated insulin resistance and impairment of cognitive-motor functionsNitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's diseaseNitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.POTENTIAL NON-GROWTH USES OF rhIGF-ISex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.si-RNA inhibition of brain insulin or insulin-like growth factor receptors causes developmental cerebellar abnormalities: relevance to fetal alcohol spectrum disorder.Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.Simulation of two-dimensional ultraviolet spectroscopy of amyloid fibrils.Human cerebral neuropathology of Type 2 diabetes mellitusType 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's DiseaseHepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitisAlzheimer's disease is type 3 diabetes-evidence reviewed.Rat strain differences in susceptibility to alcohol-induced chronic liver injury and hepatic insulin resistance.Protective effects of a Rhodiola crenulata extract and salidroside on hippocampal neurogenesis against streptozotocin-induced neural injury in the ratAltered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic ratsMetabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesRole of aspartyl-(asparaginyl)-β-hydroxylase mediated notch signaling in cerebellar development and function.Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.
P2860
Q21245063-8D357BE8-A434-438A-9566-A9C510A29BA2Q21296648-5B8F56F4-05A2-4298-AA38-3A7DF845D8CBQ26783344-2F540E9E-0AEF-4114-9AF4-84CCD219567DQ26827193-A54E79D1-D6F8-41B2-A9E8-65FD6C95E8B0Q26830845-764779DA-AD2C-4C0D-A4D6-7A9078D2177CQ26864804-618D1CA7-8C8D-41F5-899B-91C0847BF47DQ26991846-377A8593-FDC9-48ED-A28F-BF7F390ABF49Q27008997-AF642BF6-A652-4BEE-B022-E7EF3CA1AC20Q27009988-1F84D37D-E6B4-43DD-A71C-09C678236F18Q27021700-8E057E8D-7AAF-469E-98E4-93DFFB7B6E2CQ27022552-3C046E9F-A88D-4BBC-BF76-EE1DB12A8593Q27024222-F027849A-1420-476F-85DD-1620EFE66B73Q28259585-87EF5C03-F71C-48AF-BE59-337E894E8F34Q28394199-FC079875-AA36-4718-8456-EA8EC2735F08Q28394667-DE030F4E-D0B6-4DA5-9EE8-6A569AB3F53BQ28395520-57ADB804-2DA2-4833-868F-0DF30294FCBDQ28484016-74CB2A96-F982-4AFE-8732-A729513F7980Q28572572-807BE80F-588A-4518-96B0-F188CACE8258Q28742884-43D1215A-CCC2-4566-B9D7-8DB05B4D2305Q28750556-487EF7C5-8609-498F-A999-830263C75A65Q30376120-9D94CC4B-AA11-4255-86CB-B966447CA39CQ30478907-5964F43E-2324-4731-A953-97F6131D550DQ30479198-D690AD18-E98E-4FE2-8D20-F3D8C916D963Q30484122-58A0B3C4-E3D1-4CF3-9C7D-7602837D93B5Q30492205-DAC04818-9C8F-42CF-9A66-0AB84E640353Q30586321-0BCEFE3E-7964-4FFF-AE68-353FC551EDA9Q30968670-0E632555-C122-4966-A9BC-E35F06DEE250Q33543381-E70755B5-32A4-468D-9FB3-0AFC6590D65AQ33675254-2EDC3F8E-EB76-4B0A-821A-561D35EB693EQ33710643-928D2BE9-2943-4667-BF0A-2A12FD621E2DQ33828868-40657D38-DA49-4D79-84F8-CE9464AA1A2EQ33896118-AB3A85E5-F79E-422F-AD0C-0EA12446B818Q33944689-1BBFF72F-1EDA-4FF9-B7F3-06E4F486175BQ34020000-378441FA-076E-4AE8-A3FA-B6B34095F74BQ34097451-B0546C2C-6E45-409C-A7FF-C4C00BCD6234Q34123794-56858CE7-46BD-4C64-B7B3-9EDD81D17DABQ34173547-B148A38F-A393-49AA-8B0A-BDDA080A3BB0Q34288447-64A41F1A-91B7-44DD-9326-9DF27D1A8CE8Q34335246-AAC278EA-AC1A-4D33-8224-A05B05392DD0Q34432135-04790CDA-E28A-45CA-83E4-C6C22FF32FD1
P2860
Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Intracerebral streptozotocin m ...... sporadic Alzheimer's disease.
@en
Intracerebral streptozotocin m ...... sporadic Alzheimer's disease.
@nl
type
label
Intracerebral streptozotocin m ...... sporadic Alzheimer's disease.
@en
Intracerebral streptozotocin m ...... sporadic Alzheimer's disease.
@nl
prefLabel
Intracerebral streptozotocin m ...... sporadic Alzheimer's disease.
@en
Intracerebral streptozotocin m ...... sporadic Alzheimer's disease.
@nl
P2093
P356
P1476
Intracerebral streptozotocin m ...... o sporadic Alzheimer's disease
@en
P2093
Enrique J Rivera
Jack R Wands
Kathryn Doiron
Suzanne M de la Monte
P356
10.3233/JAD-2006-9102
P577
2006-03-01T00:00:00Z